microconstants > microconstants > news > Company News > MicroConstants China completed a TQT study for a new drug registration in China

MicroConstants China completed a TQT study for a new drug registration in China

2019-07-01 15:46:23
MicroConstants China completed a TQT study for a new drug registration in China 

previous:MicroConstants China PK lab passed 4th OECD GLP inspection
next:Liver Cancer Drug Candidate PTX-9908 Received Taiwan FDA IND Approval